Zimmer Biomet/ZBH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Zimmer Biomet

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.

Ticker

ZBH

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Ivan Tornos

Employees

18,000

Headquarters

Warsaw, United States

Zimmer Biomet Metrics

BasicAdvanced
$24B
Market cap
24.93
P/E ratio
$4.62
EPS
1.02
Beta
$0.96
Dividend rate
0.83%
Dividend yield
$24B
1.02066
$147.50
$102.00
1.3M
$0.96
1.656
0.802
38.31
46.009
20.65%
28.688
7.32%
4.52%
7.79%
5.14%
24.927
3.179
1.88
39.969
0.72%
0.83%
0.83%
4.85%
116.20%
6.46%

What the Analysts think about Zimmer Biomet

Analyst Ratings

Majority rating from 29 analysts.
Hold

Zimmer Biomet Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
9.12% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.9B
-2.62%
Net income
$172M
-58.87%
Profit margin
9.12%
-57.78%

Zimmer Biomet Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.78%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.82
$1.65
$2.20
$1.94
-
Expected
$1.81
$1.60
$2.15
$1.87
$1.99
Surprise
0.57%
3.28%
2.11%
3.78%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

Jun
26
Zimmer Biomet
Dividend·Ex-dividend
Jul
31
Zimmer Biomet
Dividend·Payment
$0.24
Per share

FAQs

What’s the current market cap for Zimmer Biomet stock?

Zimmer Biomet (ZBH) has a market cap of $24B as of June 15, 2024.

What is the P/E ratio for Zimmer Biomet stock?

The price to earnings (P/E) ratio for Zimmer Biomet (ZBH) stock is 24.93 as of June 15, 2024.

Does Zimmer Biomet stock pay dividends?

Yes, the Zimmer Biomet (ZBH) stock pays dividends to shareholders. As of June 15, 2024, the dividend rate is $0.96 and the yield is 0.83%. Zimmer Biomet has a payout ratio of 20.65% on a trailing twelve-month basis.

When is the next Zimmer Biomet dividend payment date?

The next Zimmer Biomet (ZBH) dividend payment is scheduled for July 31, 2024.

What is the beta indicator for Zimmer Biomet?

Zimmer Biomet (ZBH) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Zimmer Biomet stock price target?

The target price for Zimmer Biomet (ZBH) stock is $136.42, which is NaN% below the current price of $. This is an average based on projections from 24 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Zimmer Biomet stock

Buy or sell Zimmer Biomet stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing